共 50 条
- [31] The clinical study of anti-bcma car-t with humanized single-domain antibodyCYTOTHERAPY, 2020, 22 (05) : S18 - S18Han, L.Gao, Q.Zhou, K.Zhou, J.Yin, Q.Fang, B.Zhu, X.Zhang, J.Li, H.Song, Y.
- [32] Response to Anti-Bcma CAR T Cell Therapy Correlates with T Cell Exhaustion and Activation Status in T Cells at Baseline in MyelomaBLOOD, 2019, 134Wang, MengPruteanu, IulianCohen, Adam D.Garfall, Alfred L.Tian, LifengLacey, Simon F.Fraietta, Joseph A.Brogdon, JenniferDavis, MeganGonzalez, Vanessa E.Levine, Bruce L.Siegel, Don L.Milone, Michael C.Stadtmauer, Edward A.June, Carl H.Melenhorst, J. Joseph
- [33] The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple MyelomaCLINICAL CANCER RESEARCH, 2021, 27 (23) : 6580 - 6590Manjunath, Shwetha H.Cohen, Adam D.Lacey, Simon F.Davis, Megan M.Garfall, Alfred L.Melenhorst, J. JosephMaxwell, RussellArscott, W. TristramMaity, AmitJones, Joshua A.Plastaras, John P.Stadtmauer, Edward A.Levine, Bruce L.June, Carl H.Milone, Michael C.Paydar, Ima
- [34] GUILLAIN-BARRE SYNDROME FOLLOWING ANTI-BCMA CAR-T CELL THERAPYCHEST, 2023, 164 (04) : 6183A - 6184ARutenberg, David
- [35] Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase InhibitorsCANCER RESEARCH COMMUNICATIONS, 2022, 2 (03): : 158 - 171Metelo, Ana M.Jozwik, AgnieszkaLuong, Le AnhDominey-Foy, DelaneyGraham, CharlotteAttwood, CharlotteInam, ShafqatDunlop, AlanSanchez, KatyCuthill, KirstyRice, CarmelStreetly, MatthewBentley, TrevorBoldajipour, BijanSommer, CesarSasu, BarbraBenjamin, Reuben
- [36] Allogeneic Anti-Bcma CAR-T Cells Show Tumour Specific Killing Against Primary Multiple Myeloma Cells from Different Genomic Sub-GroupsBLOOD, 2019, 134Metelo, Ana M.Walker, IeuanJozwik, AgnieszkaGraham, CharlotteAttwood, CharlotteSanchez, KatyDunlop, AlanCuthill, KirstyRice, CarmelStreetly, MatthewBentley, TrevorBoldajipour, BijanSommer, CesarSasu, BarbraBenjamin, Reuben
- [37] Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of LiteratureBLOOD, 2020, 136Khan, IsrarRafae, AbdulJavaid, AnumAhmed, ZahoorQadeer, Haifza AbeeraKhan, Sana IrfanDar, Abdul JabbarKhurshid, QasimJaan, AliKhalid, FarhanAijaz, ZobiaHashmi, Mydah SajidMalik, Mustafa NadeemAnwer, Faiz
- [38] OUTCOMES AFTER ANTI-BCMA CAR T-CELLS FOR MULTIPLE MYELOMA, A RETROSPECTIVE ANALYSIS ON BEHALF OF THE CTIWP OF THE EBMTBONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 194 - 195Malard, FlorentBonneville, Edouard F.Bonifazi, FrancescaMaertens, JohanGedde-Dahl, TobiasDaskalakis, MichaelChoi, GodaEinsele, HermannBusca, AlessandroScheid, ChristofBay, Jacques-OlivierCorradini, PaoloCorral, Lucia LopezSirvent, AnneYakoub-Agha, IbrahimGagelmann, NicoHayden, PatrickGarderet, LaurentHoogenboom, Jorinde D.Kuball, JurgenDonal, McLornan P.Ruggeri, Annalisa
- [39] Incidence of Parkinsonism As a Complication of Anti-BCMA CAR-T Cell Therapy in Multiple MyelomaBLOOD, 2023, 142Singh, VaishnaviMaster, Samip
- [40] Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple MyelomaHEMASPHERE, 2022, 6 (03):Puertas, BorjaMateos, Maria-VictoriaGonzalez-Calle, Veronica